U.S. FDA approves Gilead's $94,500 hepatitis C drug

[riky]

U.S. FDA approves Gilead's $94,500 hepatitis C drug

By Deena Beasley (Reuters) - U.S. regulators on Friday approved a new hepatitis C pill from Gilead Sciences Inc, which said it will charge $94,500 for an improved 12-week course of treatment to rid patients of the liver-destroying viral infection. The daily pill, to be sold under the brand name Harvoni, combines Gilead's $84,000 pill Sovaldi with another drug, ledipasvir, and eliminates the need for two older, side-effect-laden treatments that needed to be taken along with Sovaldi. ...

Source: You are not allowed to view links. Register or Login